⌕
Axsome Therapeutics · AXSM · Nasdaq
Tenet 30 · Weak
Compare
$141.69−1.86%At closeTenet 30 · Weak
$141.69−2.68 (−1.86%)
At close: Nov 13, 2026, 4:00 PM ET· Nasdaq · USD

Axsome Therapeutics (AXSM) Stock

Axsome Therapeutics (AXSM) closed at $141.69 on Nov 13, 2026; its Tenet Score is 30 of 100 against 297 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

19 figures withheld by our checks. Each blank figure names its reason.

Key stats

Previous close
$141.69
Nov 13, 2026
Market cap
$7.5B
share price × the latest quarter's diluted weighted-average share count (vendor)
52-week range
123.00 – 260.19
low → high · as of close, Nov 13, 2026
Tenet Score
30/100
Weak · 297 Healthcare peers

Industry: Drugs

Axsome Therapeutics Inc scores 30/100. Weak. Value is the soft spot versus 297 Healthcare peers.

Tenet Score · vs sector

n=297
30/ 100
Weak
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
3
Quality
39
Health
18
Growth
60

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueFQualityDHealthFGrowthCMomentumC
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/E
—
loss
P/B
70.7×
price to book value
P/S
8.6×
price to fiscal 2025 sales
ROE
−176%
return on equity
Operating margin
−26.1%
fiscal 2025, before interest and tax
Net margin
−18.2%
of revenue kept
Current ratio
1.42
current assets to liabilities
Net debt / EBITDA
—
no_ebitda
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file

The whole report, at a glance · every card is a live peek, click any to open the section

About Axsome Therapeutics Inc

Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major d…

Composite computed Nov 13, 2026 · peer basis: Healthcare (n=297) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 106 US ETFs · top wrappers by weightSee all ETFs holding AXSM →

Similar-sized companies in Drugs

The 10 companies in this industry closest in market cap, as of Nov 13, 2026.

What sector and industry is Axsome Therapeutics in?

Axsome Therapeutics is in the Healthcare sector and the Drugs industry.

What is Axsome Therapeutics' Tenet Score?

Axsome Therapeutics' Tenet Score is 30 out of 100, ranked against 297 Healthcare peers as of Nov 13, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.